Peculiarities of ambulatory blood pressure monitoring in patients who have suffered from COVID-19

Авторы

DOI:

https://doi.org/10.26641/2307-0404.2023.4.294034

Ключевые слова:

ambulatory (daily) blood pressure monitoring, COVID-19, arterial hypertension

Аннотация

Violations of blood pressure control in patients who have had COVID-19 can be due to many pathophysiological factors. Further study of the features of blood pressure (BP) fluctuations in this category of patients will allow to diagnose arterial hypertension (AH) on time, to identify the uncontrolled course of AH and to select the optimal tactics of patients’ management. It was suggested to determine the characteristics of BP fluctuations in patients who have suffered from COVID-19 more than 12 weeks ago, based on the results of ambulatory (daily) blood pressure monitoring. 98 patients (51 men – 52.0%, 47 women – 47.9%) who have had COVID-19 infection more than 12 weeks ago were examined. Patients were divided into 2 groups – with and without a history of AH. The groups of examinees were homogeneous in age and gender. Ambulatory blood pressure monitoring (AM BP) was carried out on the CardioTens apparatus (Meditech, Hungary) according to the standard method. According to the data of AM BP in patients with AH in the anamnesis, who have suffered from COVID-19 more than 12 weeks ago, significantly higher average indicators of daily systolic blood pressure were recorded, and significant violations of the indicators of variability of systolic blood pressure during the day and night periods, pressure load during the day period, as well as a significantly higher degree and the rate of the morning rise in systolic blood pressure. In patients without a history of AH who have suffered from COVID-19 more than 12 weeks ago, in 21.4% cases there was newly diagnosed AH, in 33.3% of cases, increased variability of systolic blood pressure was observed, mainly during the day, in 21.4% of cases, the degree and speed of the morning rise of systolic blood pressure were increased, which indicated the presence of hypertensive reactions to household loads. In patients with a history of AH, in 55.3% of cases there was observed an increase in average blood pressure values per day, during the day and night periods, which was considered as ineffective blood pressure control and required an increase in the doses of previously prescribed antihypertensive drugs or the use of additional antihypertensive drugs in the treatment regimen. In patients with AH in the anamnesis, who have suffered from COVID-19 more than 12 weeks ago, reliable violations of many indicators of AM BP, deterioration of blood pressure control were recorded. In the patients, who did not have AH and who have suffered from COVID-19 more than 12 weeks ago, the presence of a hypertensive reaction to household loads and newly diagnosed AH were odserved.

Библиографические ссылки

Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA cardiology. 2020;5(7):831-40. doi: https://doi.org/10.1001/jamacardio.2020.1286

Zhao M, Wang M, Zhang J, Ye J, Xu Y, et al. Advances in the relationship between coronavirus infection and car¬diovascular diseases. Biomedicine & pharmacotherapy= = Biomedecine & pharmacotherapie. 2020;127:110230. doi: https://doi.org/10.1016/j.biopha.2020.110230

Bansal M. Cardiovascular disease and COVID-19. Diabetes & metabolic syndrome. 2020;14(3):247-50. doi: https://doi.org/10.1016/j.dsx.2020.03.013

Zhang D, Shen X, Qi X. Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ: Canadian Medical Asso-ciation journal = journal de l'Association medicale cana-dienne. 2016;188(3):E53-E63. doi: https://doi.org/10.1503/cmaj.150535

Dhakal BP, Sweitzer NK, Indik JH, Acharya D, William P. SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart. Heart Lung Circ. 2020;29(7):973-87. doi: https://doi.org/10.1016/j.hlc.2020.05.101

Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. doi: https://doi.org/10.1056/NEJMoa2002032

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Pa¬tients With Coronavirus Disease 2019 (COVID-19). JAMA cardiology. 2020;5(7):811-8. doi: https://doi.org/10.1001/jamacardio.2020.1017

Desai AD, Boursiquot BC, Melki L, Wan EY. Management of Arrhythmias Associated with COVID-19. Current cardiology reports. 2021;23(2):1-9. doi: https://doi.org/10.1007/s11886-020-01434-7

Buheruk VV, Vоlоshyna OB, Balashova IV. [Inflammatory damage to the myocardium in patients with-no¬vel coronavirus disease (COVID-19)]. Zaporozhye medi¬cal journal. 2021;23(4):555-66. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2021.4.211033

Zbitneva VO, Voloshyna OB, Balashova IV, Dukova OR, Lysiy IS. [Incidence of cardiac arrhythmias in patients with COVID-19 infectionaccording to 24-hour electrocardiogram monitoring]. Zaporizhia Medical Journal. 2021;6(129):759-65. Ukrainian. doi: https://doi.org/10.14739/2310-1210.2021.6.239243

Bryan Williams and others, 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hyper-tension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal. 2018;39(33):3021-104. doi: https://doi.org/10.1093/eurheartj/ehy339

Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-57. doi: https://doi.org/10.1161/HYPERTENSIONAHA.120.15026

Voloshyna OB, Zbitneva VO, Zubok EA, Bala-shova IV, Lysyy IS, Dukova OR, et al. [Peculiarities course of arterial hypertension in patients with accom-panying diabetes in the post-covid period]. Lviv Clinical Bulletin. 2022;1(37)-2(38):75-80. Ukrainian. doi: https://doi.org/10.25040/lkv2022.01-02.075

Angeli F, Reboldi G, Spanevello A, De Ponti R, Visca D, Marazzato J, et al. Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations. Eur J Intern Med. 2022;95:7-12. doi: https://doi.org/10.1016/j.ejim.2021.10.006

Task Force for the management of COVID-19 of the European Society of Cardiology. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Cardiovasc Res. 2022;118(6):1385-412. doi: https://doi.org/10.1093/cvr/cvab342

Task Force for the management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J. 2022;43(11):1059-103. doi: https://doi.org/10.1093/eurheartj/ehab697

Antomonov MYu. [Mathematical processing and analysis of medical and biological data]. 2nd edition. Kiev: Medinform; 2018. 579 p. Russian.

Опубликован

2023-12-22

Как цитировать

1.
Zbitnieva V, Voloshyna O, Balashova I, Zubok E, Dukova O, Kovalchuk L. Peculiarities of ambulatory blood pressure monitoring in patients who have suffered from COVID-19. Med. perspekt. [Интернет]. 22 декабрь 2023 г. [цитируется по 27 декабрь 2024 г.];28(4):71-9. доступно на: https://journals.uran.ua/index.php/2307-0404/article/view/294034

Выпуск

Раздел

CLINICAL MEDICINE